Title |
Understanding Concerns About Treatment-as-Prevention Among People with HIV who are not Using Antiretroviral Therapy
|
---|---|
Published in |
AIDS and Behavior, November 2014
|
DOI | 10.1007/s10461-014-0959-9 |
Pubmed ID | |
Authors |
C. E. Newman, J. de Wit, A. Persson, M. Holt, S. Slavin, M. R. Kidd, J. J. Post, E. Wright, L. Mao |
Abstract |
The use of antiretroviral therapy to prevent HIV transmission is now advocated in many settings, yet little research has documented the views of people with HIV. Semi-structured interviews were conducted in Australia between 2012 and 2014 with 27 HIV-positive people not using treatment at the time of interview. Thematic analysis of views on treatment-as-prevention found that while many participants recognised potential prevention benefits, only a minority was in support of initiating treatment solely to achieve those benefits. A range of uncertain or critical views were expressed regarding who would benefit, risk reduction, and changing treatment norms. Participants resisted responsibility narratives that implied treatment should be used for the public good, in favour of making considered decisions about their preferred approach to managing HIV. Engaging communities in dialogue and debate regarding the risks and benefits of treatment will be critical if this new prevention strategy is to engender public trust. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
Australia | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 40 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 8 | 20% |
Researcher | 5 | 13% |
Student > Bachelor | 3 | 8% |
Other | 3 | 8% |
Student > Master | 3 | 8% |
Other | 6 | 15% |
Unknown | 12 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Social Sciences | 10 | 25% |
Medicine and Dentistry | 7 | 18% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
Business, Management and Accounting | 2 | 5% |
Arts and Humanities | 2 | 5% |
Other | 5 | 13% |
Unknown | 12 | 30% |